Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1531039
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1531039
Insulin-like Growth Factors Market (Type: Mechano Growth Factor, Somatomedin C, and IGF 1; and End-user: Hospitals and Medical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Insulin-like Growth Factors Market - Scope of Report
TMR's report on the global insulin-like growth factors market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global insulin-like growth factors market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global insulin-like growth factors market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the insulin-like growth factors market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 274.4 Mn |
| Market Value in 2034 | US$ 511.4 Mn |
| CAGR | 5.87% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global insulin-like growth factors market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global insulin-like growth factors market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global insulin-like growth factors market.
The report delves into the competitive landscape of the global insulin-like growth factors market. Key players operating in the global insulin-like growth factors market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global insulin-like growth factors market profiled in this report.
Key Questions Answered in Global insulin-like growth factors Market Report:
- What is the sales/revenue generated by insulin-like growth factors across all regions during the forecast period?
- What are the opportunities in the global insulin-like growth factors market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Insulin-like Growth Factors Market - Research Objectives and Research Approach
The comprehensive report on the global insulin-like growth factors market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global insulin-like growth factors market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global insulin-like growth factors market.
Product Code: TMRGL86242
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Insulin-like Growth Factors (IGFs) Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Insulin-like Growth Factors (IGFs) Market Analysis and Forecast, 2020-2034
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Insulin-like Growth Factors (IGFs) Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type, 2020-2034
- 6.3.1. Mechano Growth Factor
- 6.3.2. Somatomedin C
- 6.3.3. IGF 1
- 6.4. Market Attractiveness Analysis, by Type
7. Global Insulin-like Growth Factors (IGFs) Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by End-user, 2020-2034
- 7.3.1. Hospitals
- 7.3.2. Medical Centers
- 7.4. Market Attractiveness Analysis, by End-user
8. Global Insulin-like Growth Factors (IGFs) Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region, 2020-2034
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Insulin-like Growth Factors (IGFs) Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Key Findings
- 9.3. Market Value Forecast, by Type, 2020-2034
- 9.3.1. Mechano Growth Factor
- 9.3.2. Somatomedin C
- 9.3.3. IGF 1
- 9.4. Market Value Forecast, by End-user, 2020-2034
- 9.4.1. Hospitals
- 9.4.2. Medical Centers
- 9.5. Market Value Forecast, by Country, 2020-2034
- 9.5.1. U.S.
- 9.5.2. Canada
- 9.6. Market Attractiveness Analysis
- 9.6.1. By Type
- 9.6.2. By End-user
- 9.6.3. By Country
10. Europe Insulin-like Growth Factors (IGFs) Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, by Type, 2020-2034
- 10.3.1. Mechano Growth Factor
- 10.3.2. Somatomedin C
- 10.3.3. IGF 1
- 10.4. Market Value Forecast, by End-user, 2020-2034
- 10.4.1. Hospitals
- 10.4.2. Medical Centers
- 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
- 10.5.1. Germany
- 10.5.2. U.K.
- 10.5.3. France
- 10.5.4. Italy
- 10.5.5. Spain
- 10.5.6. Rest of Europe
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Type
- 10.6.2. By End-user
- 10.6.3. By Country/Sub-region
11. Asia Pacific Insulin-like Growth Factors (IGFs) Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, by Type, 2020-2034
- 11.3.1. Mechano Growth Factor
- 11.3.2. Somatomedin C
- 11.3.3. IGF 1
- 11.4. Market Value Forecast, by End-user, 2020-2034
- 11.4.1. Hospitals
- 11.4.2. Medical Centers
- 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.5.1. China
- 11.5.2. Japan
- 11.5.3. India
- 11.5.4. Australia & New Zealand
- 11.5.5. Rest of Asia Pacific
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Type
- 11.6.2. By End-user
- 11.6.3. By Country/Sub-region
12. Latin America Insulin-like Growth Factors (IGFs) Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.2.1. Mechano Growth Factor
- 12.2.2. Somatomedin C
- 12.2.3. IGF 1
- 12.3. Market Value Forecast, by End-user, 2020-2034
- 12.3.1. Hospitals
- 12.3.2. Medical Centers
- 12.4. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Type
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Insulin-like Growth Factors (IGFs) Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Key Findings
- 13.3. Market Value Forecast, by Type, 2020-2034
- 13.3.1. Mechano Growth Factor
- 13.3.2. Somatomedin C
- 13.3.3. IGF 1
- 13.4. Market Value Forecast, by End-user, 2020-2034
- 13.4.1. Hospitals
- 13.4.2. Medical Centers
- 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.5.1. GCC Countries
- 13.5.2. South Africa
- 13.5.3. Rest of Middle East & Africa
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Type
- 13.6.2. By End-user
- 13.6.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 14.2. Market Share Analysis, by Company (2023)
- 14.3. Company Profiles
- 14.3.1. Boehringer Ingelheim International GmbH
- 14.3.1.1. Company Overview
- 14.3.1.2. Product Portfolio
- 14.3.1.3. SWOT Analysis
- 14.3.1.4. Financial Overview
- 14.3.1.5. Strategic Overview
- 14.3.2. Genervon Biopharmaceuticals LLC
- 14.3.2.1. Company Overview
- 14.3.2.2. Product Portfolio
- 14.3.2.3. SWOT Analysis
- 14.3.2.4. Financial Overview
- 14.3.2.5. Strategic Overview
- 14.3.3. Ascendis Pharma
- 14.3.3.1. Company Overview
- 14.3.3.2. Product Portfolio
- 14.3.3.3. SWOT Analysis
- 14.3.3.4. Financial Overview
- 14.3.3.5. Strategic Overview
- 14.3.4. Regulaxis SAS
- 14.3.4.1. Company Overview
- 14.3.4.2. Product Portfolio
- 14.3.4.3. SWOT Analysis
- 14.3.4.4. Financial Overview
- 14.3.4.5. Strategic Overview
- 14.3.5. MedImmune, LLC
- 14.3.5.1. Company Overview
- 14.3.5.2. Product Portfolio
- 14.3.5.3. SWOT Analysis
- 14.3.5.4. Financial Overview
- 14.3.5.5. Strategic Overview
- 14.3.1. Boehringer Ingelheim International GmbH
Product Code: TMRGL86242
List of Tables
- Table 01: Global Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 02: Global Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
- Table 03: Global Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Region, 2020-2034
- Table 04: North America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Country, 2020-2034
- Table 05: North America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 06: North America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
- Table 07: Europe Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 08: Europe Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 09: Europe Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
- Table 10: Asia Pacific Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 11: Asia Pacific Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 12: Asia Pacific Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
- Table 13: Latin America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 14: Latin America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 15: Latin America Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
- Table 16: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
- Table 17: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by Type, 2020-2034
- Table 18: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
- Figure 01: Global Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
- Figure 02: Global Insulin-like Growth Factors (IGFs) Market Revenue (US$ Mn), by Type, 2023
- Figure 03: Global Insulin-like Growth Factors (IGFs) Market Value Share, by Type, 2023
- Figure 04: Global Insulin-like Growth Factors (IGFs) Market Revenue (US$ Mn), by End-user, 2023
- Figure 05: Global Insulin-like Growth Factors (IGFs) Market Value Share, by End-user, 2023
- Figure 06: Global Insulin-like Growth Factors (IGFs) Market Value Share, by Region, 2023
- Figure 07: Global Insulin-like Growth Factors (IGFs) Market Value (US$ Mn) Forecast, 2020-2034
- Figure 08: Global Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 09: Global Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 10: Global Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 11: Global Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
- Figure 12: Global Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Region, 2023 and 2034
- Figure 13: Global Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Region, 2020-2034
- Figure 14: North America Insulin-like Growth Factors (IGFs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 15: North America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Country, 2020-2034
- Figure 16: North America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Country, 2023 and 2034
- Figure 17: North America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 18: North America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 19: North America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 20: North America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
- Figure 21: Europe Insulin-like Growth Factors (IGFs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 22: Europe Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
- Figure 23: Europe Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 24: Europe Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 25: Europe Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 26: Europe Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 27: Europe Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
- Figure 28: Asia Pacific Insulin-like Growth Factors (IGFs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 29: Asia Pacific Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
- Figure 30: Asia Pacific Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 31: Asia Pacific Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 32: Asia Pacific Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 33: Asia Pacific Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 34: Asia Pacific Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
- Figure 35: Latin America Insulin-like Growth Factors (IGFs) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 36: Latin America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
- Figure 37: Latin America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 38: Latin America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 39: Latin America Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 40: Latin America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 41: Latin America Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
- Figure 42: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
- Figure 43: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
- Figure 44: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
- Figure 45: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by Type, 2023 and 2034
- Figure 46: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Value Share Analysis, by End-user, 2023 and 2034
- Figure 47: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by Type, 2020-2034
- Figure 48: Middle East & Africa Insulin-like Growth Factors (IGFs) Market Attractiveness Analysis, by End-user, 2020-2034
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.